PharVision Advisers’s Sanmina SANM Stock Holding History

PharVision Advisers’s Portfolio SANM Stock Details SANM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,541	Closed	-$231K	–	542
2025 Q4	$231K	Buy	+1,541	New	+$227K	0.12%	440

Other funds holding SANM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AMD

Advanced Micro Devices Santa Clara, California $174M AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PharVision Advisers's SANM Position: Q1 2026 in Review

PharVision Advisers sold out of Sanmina (SANM) in Q1 2026, closing a stake of 1,541 shares — an estimated $231K sold.

PharVision Advisers first reported a position in SANM in Q4 2025 and held it in 1 quarter. The position peaked at $231K in Q4 2025. 457 funds tracked by Wall St. Rank hold SANM as of Q1 2026.

PharVision Advisers reported no remaining Sanmina position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,541 Sanmina shares in Q1 2026, an estimated $231K.
PharVision Advisers first reported a position in Sanmina in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Sanmina position peaked at $231K in Q4 2025.
457 funds tracked by Wall St. Rank held Sanmina as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.